(Q48389923)

11 February 2018

title

White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up. (English)

1 reference

11 February 2018

enzyme replacement therapy

main subject

0 references

1 reference

1

Laura B Jardim

1 reference

11 February 2018

Roberto Giugliani

12

object named as

Roberto Giugliani

1 reference

11 February 2018

Cristina Brinkmann Oliveira Netto

8

object named as

Cristina B O Netto

1 reference

11 February 2018

Luciane Kalakun

11

object named as

Luciane Kalakun

1 reference

11 February 2018

author name string

Flávio Aesse

2

1 reference

11 February 2018

Leonardo M Vedolin

3

1 reference

11 February 2018

Cláudio Pitta-Pinheiro

4

1 reference

11 February 2018

João Marconato

5

1 reference

11 February 2018

Maira G Burin

6

1 reference

11 February 2018

Cláudia Cecchin

7

1 reference

11 February 2018

Ursula S Matte

9

1 reference

11 February 2018

Fernanda Pereira

10

1 reference

11 February 2018

publication date

1 September 2006

1 reference

11 February 2018

Arquivos de Neuro-Psiquiatria

published in

1 reference

11 February 2018

volume

64

1 reference

11 February 2018

issue

3B

1 reference

11 February 2018

page(s)

711-717

1 reference

11 February 2018

Quantitative analysis of cerebral vasculopathy in patients with Fabry disease.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Fabry disease: overall effects of agalsidase alfa treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Cerebrovascular complications of Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Natural history of Fabry disease in males: preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2006000500002

10.1590/S0004-282X2006000500002

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

17057872

1 reference

11 February 2018